2021
DOI: 10.1097/md.0000000000024255
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of the expression of metastasis-associated in colon cancer-1 in gynecologic cancers and breast cancer

Abstract: Background: The prognostic role of the expression of metastasis-associated in colon cancer-1 (MACC1) in gynecologic cancers and breast cancer remains unclear. The aim of this systematic review and meta-analysis was to determine the prognostic significance of MACC1 expression in gynecologic cancers and breast cancer. Materials and methods: PubMed, Web of Science and Embase were comprehensively searched up to February 9, 2020. Studies focusing on the rela… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…in cell culture, as well as carcinogenesis and metastases in several mouse models ( 13 , 15 , 16 ). Since the discovery of MACC1, the authors of the present study, as well as several other research groups have demonstrated the clinical significance of MACC1 as a causal, prognostic and predictive biomarker for >20 solid cancer types ( 14 ), including meta-analyses for solid cancers, cancers of the digestive system, colorectal, hepatocellular, gastric, gynecological and breast cancer ( 17 - 22 ). The causal contribution of MACC1 for rewiring cell metabolism has been demonstrated by the authors of the present study, as well as others ( 23 - 25 ).…”
Section: Introductionmentioning
confidence: 79%
“…in cell culture, as well as carcinogenesis and metastases in several mouse models ( 13 , 15 , 16 ). Since the discovery of MACC1, the authors of the present study, as well as several other research groups have demonstrated the clinical significance of MACC1 as a causal, prognostic and predictive biomarker for >20 solid cancer types ( 14 ), including meta-analyses for solid cancers, cancers of the digestive system, colorectal, hepatocellular, gastric, gynecological and breast cancer ( 17 - 22 ). The causal contribution of MACC1 for rewiring cell metabolism has been demonstrated by the authors of the present study, as well as others ( 23 - 25 ).…”
Section: Introductionmentioning
confidence: 79%
“…Despite the fact that several studies have discussed the prognostic value of MACC1 expression in BCs ( Table 1 ), no firm conclusions have been reached because of the contradictory findings caused by the small sample sizes of earlier studies. To ascertain the predictive significance of MACC1 expression in gynecologic and BC, Wang et al [ 68 ] conducted a meta-analysis of 1811 patients included in a comprehensive search of databases such as PubMed, Web of Science, and Embase to determine the prognostic value of MACC1 expression in BC. High expression of MACC1 in BCs predicts shorter OS and RFS, poorer tumor differentiation, more advanced FIGO staging, and earlier lymph node metastasis.…”
Section: Effect Of Macc1 Overexpression On Bcmentioning
confidence: 99%
“…MACC1 has been established by us and many other groups as crucial for tumor development and metastasis. Thus, it has been found to be a prognostic and predictive biomarker for tumor progression and metastasis formation in a multitude of solid cancer types, including supportive meta-analyses for solid cancers; hepatocellular and gastrointestinal tract cancers, such as CRC and gastric cancer; and gynecological and breast cancer [ 7 , 8 , 9 , 10 , 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%